The present invention relates to the field of metabolic disorders including type II diabetes and obesity. Specifically the invention relates to methods of treating and/or preventing a metabolic disorder with an IL 18 antagonist in particular an anti IL 18 antigen binding protein in particular an anti IL 18 antibody.